DIAJARD FORTE XR 10/5/1000MG 14S TAB

DIAJARD FORTE XR 10/5/1000MG Tablets is a triple combination therapy used for the management of Type 2 Diabetes Mellitus. It contains Empagliflozin (10mg), Linagliptin (5mg), and Metformin XR (1000mg) — three powerful antidiabetic agents that work together to control blood sugar levels, improve insulin sensitivity, and reduce glucose production and absorption. This extended-release (XR) formulation ensures long-lasting glycemic control with once-daily dosing convenience.

Uses:

• Helps in the management of Type 2 Diabetes Mellitus

• Controls high blood sugar in adults

• Reduces the risk of diabetes-related complications like kidney damage, nerve issues, and vision problems

• Improves insulin sensitivity and glucose metabolism

• Supports weight management and may reduce cardiovascular risk

Benefits:

• Empagliflozin: Promotes glucose excretion through urine by inhibiting SGLT2, lowering blood sugar and aiding weight loss

• Linagliptin: Increases insulin release and decreases glucagon secretion for better glucose control

• Metformin XR: Reduces glucose production in the liver and improves insulin utilization

• Provides triple-action control for stable and sustained blood sugar management

• Once-daily extended-release formulation improves compliance and reduces gastrointestinal discomfort

• May help reduce cardiovascular events in diabetic patients

Possible Side Effects:

• Common: Nausea, diarrhea, mild stomach upset, or headache

• Rare but serious: Hypoglycemia (low blood sugar), dehydration, urinary tract infection, or genital infections

• Long-term or improper use may affect kidney function — use under medical supervision only

Precautions:

• Take once daily with food or as prescribed by your doctor

• Monitor blood sugar and kidney function regularly

• Avoid alcohol to prevent lactic acidosis

• Not recommended in Type 1 diabetes or severe renal impairment

• Consult your doctor if you experience persistent fatigue, muscle pain, or signs of infection